Ternes, D., Tsenkova, M., Pozdeev, V., Meyers, M., Koncina, E., Atatri, S., Schmitz, M., Karta, J., Schmoetten, M., Heinken, A., Rodriguez, F., Delbrouck, C., Gaigneaux, A., Ginolhac, A., Dan Nguyen, T. T., Grandmougin, L., Frachet-Bour, A., Martin-Gallausiaux, C., Pires Pacheco, M. I., ... Letellier, E. (2022). The gut microbial metabolite formate exacerbates colorectal cancer progression. Nature Metabolism. doi:10.1038/s42255-022-00558-0 Peer reviewed |
Ternes, D., Karta, J., Tsenkova, M., Koncina, E., Schmitz, M., Grandmougin, L., Ginolhac, A., Gaigneaux, A., Ramiro Garcia, J., Wilmes, P., Haan, S., & Letellier, E. (22 February 2020). Understanding the role of Fusobacterium nucleatum metabolism in colon cancer initiation and progression [Poster presentation]. The Microbiome, Viruses, and Cancer, Orlando, United States. |
Qureshi-Baig, K., Kuhn, Viry, E., Pozdeev, V., Schmitz, M., Rodriguez, F., Ullmann, P., Koncina, E., Nurmik, M., Frasquilho, S., Nazarov, P. V., Zuegel, N., Boulmont, M., Karapetyan, Y., Antunes, L., Val, D., Mittelbronn, M., Janji, B., Haan, S., & Letellier, E. (2019). Hypoxia-induced Autophagy Drives Colorectal Cancer Initiation and Progression by Activating the PRKC/PKC-EZR (Ezrin) Pathway. Autophagy. doi:10.1080/15548627.2019.1687213 Peer Reviewed verified by ORBi |
Ullmann, P., Nurmik, M., Schmitz, M., Rodriguez, F., Weilerr, J., Baig, K., Felten, P., Nazarov, P., NICOT, N., Zuegel, N., Haan, S., & Letellier, E. (May 2019). Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity. Cancer Letters, 450, 32-41. doi:10.1016/j.canlet.2019.02.030 Peer Reviewed verified by ORBi |
Gerard, D., Schmidt, F., Ginolhac, A., Schmitz, M., Halder, R., Ebert, P., Schulz, M., Sauter, T., & Sinkkonen, L. (2018). Temporal enhancer profiling of parallel lineages identifies AHR and GLIS1 as regulators of mesenchymal multipotency. Nucleic Acids Research. doi:10.1093/nar/gky1240 Peer Reviewed verified by ORBi |
Ullmann, P., Rodriguez, F., Schmitz, M., Meurer, S. K., Qureshi-Baig, K., Felten, P., Ginolhac, A., Antunes, L., Frasquilho, S., Zugel, N., Weiskirchen, R., Haan, S., & Letellier, E. (2018). The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis. Cancer Research. doi:10.1158/0008-5472.CAN-17-3003 Peer Reviewed verified by ORBi |
Letellier, E., Schmitz, M., Ginolhac, A., Rodriguez, F., Ullmann, P., Qureshi-Baig, K., Frasquilho, S., Antunes, L., & Haan, S. (21 November 2017). Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence. British Journal of Cancer, 117 (11), 1689-1701. doi:10.1038/bjc.2017.352 Peer Reviewed verified by ORBi |
Bahlawane, C., Schmitz, M., Letellier, E., Arumugam, K., Nicot, N., Nazarov, P., & Haan, S. (2017). Insights into ligand stimulation effects on gastro-intestinal stromal tumors signalling. Cell Signal. doi:10.1016/j.cellsig.2016.10.009 Peer reviewed |
Bahlawane, C., Schmitz, M., Letellier, E., Arumugam, K., Nicot, N., Nazarov, P., & Haan, S. (2016). Data on quantification of signaling pathways activated by KIT and PDGFRA mutants. Data in Brief, (9), 828-838. doi:10.1016/j.dib.2016.10.026 Peer Reviewed verified by ORBi |
Letellier, E., Schmitz, M., Baig, K., Beaume, N., Schwartz, C., Frasquilho, S., Antunes, L., Marcon, N., Nazarov, P. V., Vallar, L., Even, J., & Haan, S. (2014). Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. British Journal of Cancer, 111 (4), 726-35. doi:10.1038/bjc.2014.377 Peer Reviewed verified by ORBi |
Schmitz, M., Grignard, G., Margue, C., Dippel, W., Capesius, C., Mossong, J., Nathan, M., Giacchi, S., Scheiden, R., & Kieffer, N. (2007). Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis. International Journal of Cancer, 120 (6), 1284-92. doi:10.1002/ijc.22359 Peer Reviewed verified by ORBi |